Madrid, 15 de febrer<\/em>. Infarma Madrid 2022 obrir\u00e0 un espai de coneixement i debat on destacats experts i cient\u00edfics abordaran les investigacions en curs sobre el desenvolupament de tractaments i vacunes que poden marcar el final de l’actual emerg\u00e8ncia sanit\u00e0ria, presentaran les estrat\u00e8gies posades en marxa per fer front amb \u00e8xit a virus respiratoris com el SARS-CoV-2 i donaran resposta a diverses preguntes sobre l’evoluci\u00f3 de la pand\u00e8mia.<\/p>\n![\"\"](\"https:\/\/www.cofb.org\/documents\/10136\/1091470\/sala_espacio_debate_covid+%281%29.jpg\/7b9980e4-f2c6-40ab-910f-e869432c914e?t=1645013579524\")
<\/p>\n
El programa cient\u00edfic del Congr\u00e9s i Sal\u00f3 de la farm\u00e0cia que organitzen els Col\u00b7legis Oficials de Farmac\u00e8utics de Madrid i Barcelona, en col\u00b7laboraci\u00f3 amb Interalia, inclou tres pon\u00e8ncies i una taula rodona que se celebraran a la Sala Espai Debat COVID, oberta al pavell\u00f3 5 del recinte firal d\u2019Ifema.<\/p>\n
Luis Enjuanes, professor d\u2019Investigaci\u00f3 del CSIC i cap del laboratori de coronavirus del Centro Nacional de Biotecnolog\u00eda (CNB-CSIC), ser\u00e0 el primer a analitzar, el dimarts 22 de mar\u00e7, l’origen i evoluci\u00f3 de la pand\u00e8mia per SARS-CoV-2: desenvolupament de vacunes<\/strong><\/em>. L’investigador descriur\u00e0, en la seva pon\u00e8ncia, l’habilitat dels coronavirus per creuar la barrera de les esp\u00e8cies i la necessitat de trobar l’origen del SARS-CoV-2. Aix\u00ed mateix, revisar\u00e0 una comparaci\u00f3 dels tres coronavirus mortals per les persones, juntament amb les bases moleculars de la seva patogenicitat, i el desenvolupament de vacunes per prevenir la infecci\u00f3 per coronavirus.<\/p>\nEn aquest mateix escenari, el 23 de mar\u00e7 tindr\u00e0 lloc la taula rodona Present i futur del SARS-CoV-2. De pand\u00e8mia a end\u00e8mia? Amb la moderaci\u00f3 del divulgador cient\u00edfic de RNE, Manuel Seara<\/strong>, intervindran com a ponents Julio Mayol<\/strong>, director m\u00e8dic de l’Hospital Cl\u00ednico San Carlos de Madrid; Jose Antonio L\u00f3pez<\/strong>, director de Neurovirologia de la Universidad Aut\u00f3noma de Madrid; Olga Mediano<\/strong>, pneum\u00f2loga de l’Hospital Universitario de Guadalajara i membre de la Sociedad Espa\u00f1ola de Pneumolog\u00eda y Cirug\u00eda Tor\u00e1cica; Alfredo Corell Almuzara<\/strong>, catedr\u00e0tic d’Immunologia i vicerector d’Innovaci\u00f3 Docent i Transformaci\u00f3 Digital de la Universidad de Valladolid; i Juan Torres<\/strong>, cap de servei de Medicina Interna de l’Hospital Universitario Infanta Leonor-Virgen De la Torre.<\/p>\nA la tarda, el doctor Urtzi Garaigorta de Dios<\/strong>, investigador Ram\u00f3n y Cajal al Centro Nacional de Biotecnolog\u00eda (CNB), codirector i cocoordinador de les plataformes de cerques d\u2019antivirals del CNB y de la PTI+ Salut Global del CSIC, presentar\u00e0 a la seva pon\u00e8ncia Plataforma de cribratge de mol\u00e8cules antivirals davant del SARS-CoV-2 i altres virus<\/em><\/strong> com va sorgir aquesta iniciativa de cerca d’antivirals i la gran resposta cient\u00edfica i col\u00b7laborativa que ha obtingut. Avan\u00e7ar\u00e0 alguns dels resultats m\u00e9s interessants que estan aconseguint i exposar\u00e0 les perspectives a mitj\u00e0 i llarg termini obertes per aquesta mena de plataformes, que permetran estar m\u00e9s ben preparats davant futures pand\u00e8mies.<\/p>\nFinalment, Mar\u00eda de la Monta\u00f1a Iglesias<\/strong>, investigadora del Laboratorio de Referencia de Gripe y Virus Respiratorios del Centro Nacional de Microbiolog\u00eda (CNM), pertanyent a l’Instituto de Salud Carlos III, oferir\u00e0 la seva visi\u00f3 experta de la Gesti\u00f3 d’una pand\u00e8mia: Coronavirus, paradigma de control de pand\u00e8mies<\/em>. A m\u00e9s de fer un rep\u00e0s hist\u00f2ric de pand\u00e8mies pr\u00e8vies associades a virus respiratoris o a situacions que van generar una alerta sanit\u00e0ria, presentar\u00e0 les estrat\u00e8gies de resposta i les metodologies que inclouen els abordatges cl\u00e0ssics d’estudi de virus fins al desenvolupament de noves t\u00e8cniques de seq\u00fcenciaci\u00f3 del virus SARS-CoV-2, que han suposat una innovaci\u00f3 en els sistemes de vigil\u00e0ncia de virus respiratoris. Mostrar\u00e0 tamb\u00e9 les aproximacions realitzades pel Laboratorio de Referencia e Investigaci\u00f3n del ISCIII per afrontar aquest repte de salut p\u00fablica i el desenvolupament de la Xarxa de Laboratoris de seq\u00fcenciaci\u00f3 gen\u00f2mica del SARS-CoV-2 a trav\u00e9s del Programa HERA-Incubator.<\/p>\nSobre Infarma Madrid 2022<\/h3>\n
El Congr\u00e9s Europeu d’Oficina de Farm\u00e0cia \u00e9s una cita professional reconeguda d’inter\u00e8s sanitari per part del Ministerio de Sanidad. En la seva \u00faltima edici\u00f3 de 2018 a Madrid, ja que Infarma 2020 va quedar en suspens davant la irrupci\u00f3 de la pand\u00e8mia, va reunir 33.850 visitants i a 3.450 congressistes. Des que els Col\u00b7legis Farmac\u00e8utics de Madrid i Barcelona van decidir col\u00b7laborar per organitzar Infarma de manera conjunta juntament amb Interalia, el creixement del Congr\u00e9s i Sal\u00f3 ha estat sostingut en cada edici\u00f3. Si el 2012, data de la primera trobada conjunta, es va aconseguir reunir 2.356 congressistes i 21.000 visitants, l’\u00faltima edici\u00f3 de Barcelona de 2019 es va tancar amb un balan\u00e7 de 3.480 congressistes i 33.770 visitants, un 47 per cent m\u00e9s de congressistes i un 60 per cent m\u00e9s de professionals. S\u00f3n algunes de les grans xifres d’un Congr\u00e9s que el 2018 va aconseguir, a m\u00e9s, un nou r\u00e8cord d’espai firal en contractar 35.000 metres quadrats, aix\u00ed com d’expositors, amb 387 empreses i laboratoris presents.<\/p>\n
\u00a0El Congr\u00e9s i Sal\u00f3 de la farm\u00e0cia programa tres pon\u00e8ncies i una taula rodona a la Sala Espai Debat COVID per analitzar de la m\u00e0 d’experts i investigadors capdavanters els or\u00edgens, l’evoluci\u00f3 i les estrat\u00e8gies avan\u00e7ades per\u00a0 sortir de la pand\u00e8mia.<\/p>\n
\u00a0<\/p>\n
Madrid, 15 de febrer. Infarma Madrid 2022 obrir\u00e0 un espai de coneixement i debat on destacats experts i cient\u00edfics abordaran les investigacions en curs sobre el desenvolupament de tractaments i vacunes que poden marcar el final de l’actual emerg\u00e8ncia sanit\u00e0ria, presentaran les estrat\u00e8gies posades en marxa per fer front amb \u00e8xit a virus respiratoris com el SARS-CoV-2 i donaran resposta a diverses preguntes sobre l’evoluci\u00f3 de la pand\u00e8mia.<\/p>\n
El programa cient\u00edfic del Congr\u00e9s i Sal\u00f3 de la farm\u00e0cia que organitzen els Col\u00b7legis Oficials de Farmac\u00e8utics de Madrid i Barcelona, en col\u00b7laboraci\u00f3 amb Interalia, inclou tres pon\u00e8ncies i una taula rodona que se celebraran a la Sala Espai Debat COVID, oberta al pavell\u00f3 5 del recinte firal d\u2019Ifema.<\/p>\n
Luis Enjuanes, professor d\u2019Investigaci\u00f3 del CSIC i cap del laboratori de coronavirus del Centro Nacional de Biotecnolog\u00eda (CNB-CSIC), ser\u00e0 el primer a analitzar, el dimarts 22 de mar\u00e7, l’origen i evoluci\u00f3 de la pand\u00e8mia per SARS-CoV-2: desenvolupament de vacunes. L’investigador descriur\u00e0, en la seva pon\u00e8ncia, l’habilitat dels coronavirus per creuar la barrera de les esp\u00e8cies i la necessitat de trobar l’origen del SARS-CoV-2. Aix\u00ed mateix, revisar\u00e0 una comparaci\u00f3 dels tres coronavirus mortals per les persones, juntament amb les bases moleculars de la seva patogenicitat, i el desenvolupament de vacunes per prevenir la infecci\u00f3 per coronavirus.<\/p>\n
En aquest mateix escenari, el 23 de mar\u00e7 tindr\u00e0 lloc la taula rodona Present i futur del SARS-CoV-2. De pand\u00e8mia a end\u00e8mia? Amb la moderaci\u00f3 del divulgador cient\u00edfic de RNE, Manuel Seara, intervindran com a ponents Julio Mayol, director m\u00e8dic de l’Hospital Cl\u00ednico San Carlos de Madrid; Jose Antonio L\u00f3pez, director de Neurovirologia de la Universidad Aut\u00f3noma de Madrid; Olga Mediano, pneum\u00f2loga de l’Hospital Universitario de Guadalajara i membre de la Sociedad Espa\u00f1ola de Pneumolog\u00eda y Cirug\u00eda Tor\u00e1cica; Alfredo Corell Almuzara, catedr\u00e0tic d’Immunologia i vicerector d’Innovaci\u00f3 Docent i Transformaci\u00f3 Digital de la Universidad de Valladolid; i Juan Torres, cap de servei de Medicina Interna de l’Hospital Universitario Infanta Leonor-Virgen De la Torre.<\/p>\n
A la tarda, el doctor Urtzi Garaigorta de Dios, investigador Ram\u00f3n y Cajal al Centro Nacional de Biotecnolog\u00eda (CNB), codirector i cocoordinador de les plataformes de cerques d\u2019antivirals del CNB y de la PTI+ Salut Global del CSIC, presentar\u00e0 a la seva pon\u00e8ncia Plataforma de cribratge de mol\u00e8cules antivirals davant del SARS-CoV-2 i altres virus com va sorgir aquesta iniciativa de cerca d’antivirals i la gran resposta cient\u00edfica i col\u00b7laborativa que ha obtingut. Avan\u00e7ar\u00e0 alguns dels resultats m\u00e9s interessants que estan aconseguint i exposar\u00e0 les perspectives a mitj\u00e0 i llarg termini obertes per aquesta mena de plataformes, que permetran estar m\u00e9s ben preparats davant futures pand\u00e8mies.<\/p>\n
Finalment, Mar\u00eda de la Monta\u00f1a Iglesias, investigadora del Laboratorio de Referencia de Gripe y Virus Respiratorios del Centro Nacional de Microbiolog\u00eda (CNM), pertanyent a l’Instituto de Salud Carlos III, oferir\u00e0 la seva visi\u00f3 experta de la Gesti\u00f3 d’una pand\u00e8mia: Coronavirus, paradigma de control de pand\u00e8mies. A m\u00e9s de fer un rep\u00e0s hist\u00f2ric de pand\u00e8mies pr\u00e8vies associades a virus respiratoris o a situacions que van generar una alerta sanit\u00e0ria, presentar\u00e0 les estrat\u00e8gies de resposta i les metodologies que inclouen els abordatges cl\u00e0ssics d’estudi de virus fins al desenvolupament de noves t\u00e8cniques de seq\u00fcenciaci\u00f3 del virus SARS-CoV-2, que han suposat una innovaci\u00f3 en els sistemes de vigil\u00e0ncia de virus respiratoris. Mostrar\u00e0 tamb\u00e9 les aproximacions realitzades pel Laboratorio de Referencia e Investigaci\u00f3n del ISCIII per afrontar aquest repte de salut p\u00fablica i el desenvolupament de la Xarxa de Laboratoris de seq\u00fcenciaci\u00f3 gen\u00f2mica del SARS-CoV-2 a trav\u00e9s del Programa HERA-Incubator.<\/p>\n
Sobre Infarma Madrid 2022<\/p>\n
El Congr\u00e9s Europeu d’Oficina de Farm\u00e0cia \u00e9s una cita professional reconeguda d’inter\u00e8s sanitari per part del Ministerio de Sanidad. En la seva \u00faltima edici\u00f3 de 2018 a Madrid, ja que Infarma 2020 va quedar en suspens davant la irrupci\u00f3 de la pand\u00e8mia, va reunir 33.850 visitants i a 3.450 congressistes. Des que els Col\u00b7legis Farmac\u00e8utics de Madrid i Barcelona van decidir col\u00b7laborar per organitzar Infarma de manera conjunta juntament amb Interalia, el creixement del Congr\u00e9s i Sal\u00f3 ha estat sostingut en cada edici\u00f3. Si el 2012, data de la primera trobada conjunta, es va aconseguir reunir 2.356 congressistes i 21.000 visitants, l’\u00faltima edici\u00f3 de Barcelona de 2019 es va tancar amb un balan\u00e7 de 3.480 congressistes i 33.770 visitants, un 47 per cent m\u00e9s de congressistes i un 60 per cent m\u00e9s de professionals. S\u00f3n algunes de les grans xifres d’un Congr\u00e9s que el 2018 va aconseguir, a m\u00e9s, un nou r\u00e8cord d’espai firal en contractar 35.000 metres quadrats, aix\u00ed com d’expositors, amb 387 empreses i laboratoris presents.\u00a0\u00a0COFB.ORG<\/p>\n","protected":false},"excerpt":{"rendered":"
\u00a0 El Congr\u00e9s i Sal\u00f3 de la farm\u00e0cia programa tres pon\u00e8ncies i una taula rodona a la Sala Espai Debat COVID per analitzar de la m\u00e0 d’experts i investigadors capdavanters els or\u00edgens, l’evoluci\u00f3 i les estrat\u00e8gies avan\u00e7ades per\u00a0 sortir de la pand\u00e8mia. \u00a0 Madrid, 15 de febrer. Infarma Madrid 2022 […]<\/p>\n","protected":false},"author":1,"featured_media":77023,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1060,1066],"tags":[],"class_list":["post-77022","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notes-premsa","category-sense-categoria-ca"],"yoast_head":"\n
\u2018Infarma Madrid 2022\u2019 obre un espai de debat i coneixement cient\u00edfic al voltant del SARS-CoV-2 - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u2018Infarma Madrid 2022\u2019 obre un espai de debat i coneixement cient\u00edfic al voltant del SARS-CoV-2 - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u00a0 El Congr\u00e9s i Sal\u00f3 de la farm\u00e0cia programa tres pon\u00e8ncies i una taula rodona a la Sala Espai Debat COVID per analitzar de la m\u00e0 d’experts i investigadors capdavanters els or\u00edgens, l’evoluci\u00f3 i les estrat\u00e8gies avan\u00e7ades per\u00a0 sortir de la pand\u00e8mia. \u00a0 Madrid, 15 de febrer. Infarma Madrid 2022 […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-16T13:13:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"852\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"\u2018Infarma Madrid 2022\u2019 obre un espai de debat i coneixement cient\u00edfic al voltant del SARS-CoV-2\",\"datePublished\":\"2022-02-16T13:13:00+00:00\",\"dateModified\":\"2022-02-16T13:13:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/\"},\"wordCount\":1767,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr.jpeg\",\"articleSection\":[\"Notes de premsa\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/\",\"name\":\"\u2018Infarma Madrid 2022\u2019 obre un espai de debat i coneixement cient\u00edfic al voltant del SARS-CoV-2 - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr.jpeg\",\"datePublished\":\"2022-02-16T13:13:00+00:00\",\"dateModified\":\"2022-02-16T13:13:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr.jpeg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr.jpeg\",\"width\":852,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u2018Infarma Madrid 2022\u2019 obre un espai de debat i coneixement cient\u00edfic al voltant del SARS-CoV-2\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u2018Infarma Madrid 2022\u2019 obre un espai de debat i coneixement cient\u00edfic al voltant del SARS-CoV-2 - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/","og_locale":"ca_ES","og_type":"article","og_title":"\u2018Infarma Madrid 2022\u2019 obre un espai de debat i coneixement cient\u00edfic al voltant del SARS-CoV-2 - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u00a0 El Congr\u00e9s i Sal\u00f3 de la farm\u00e0cia programa tres pon\u00e8ncies i una taula rodona a la Sala Espai Debat COVID per analitzar de la m\u00e0 d’experts i investigadors capdavanters els or\u00edgens, l’evoluci\u00f3 i les estrat\u00e8gies avan\u00e7ades per\u00a0 sortir de la pand\u00e8mia. \u00a0 Madrid, 15 de febrer. Infarma Madrid 2022 […]","og_url":"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2022-02-16T13:13:00+00:00","og_image":[{"width":852,"height":300,"url":"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr.jpeg","type":"image\/jpeg"}],"author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"9 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"\u2018Infarma Madrid 2022\u2019 obre un espai de debat i coneixement cient\u00edfic al voltant del SARS-CoV-2","datePublished":"2022-02-16T13:13:00+00:00","dateModified":"2022-02-16T13:13:00+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/"},"wordCount":1767,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr.jpeg","articleSection":["Notes de premsa"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/","url":"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/","name":"\u2018Infarma Madrid 2022\u2019 obre un espai de debat i coneixement cient\u00edfic al voltant del SARS-CoV-2 - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr.jpeg","datePublished":"2022-02-16T13:13:00+00:00","dateModified":"2022-02-16T13:13:00+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr.jpeg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr.jpeg","width":852,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2022\/02\/16\/infarma-madrid-2022-obre-un-espai-de-debat-i-coneixement-cientific-al-voltant-del-sars-cov-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"\u2018Infarma Madrid 2022\u2019 obre un espai de debat i coneixement cient\u00edfic al voltant del SARS-CoV-2"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr.jpeg",852,300,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr-150x150.jpeg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr-300x106.jpeg",300,106,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr-768x270.jpeg",768,270,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr.jpeg",852,300,false],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr.jpeg",852,300,false],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr.jpeg",852,300,false],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2022\/02\/7b9980e4-f2c6-40ab-910f-e869432c914e-2Auwpr-18x6.jpeg",18,6,true]},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u00a0 El Congr\u00e9s i Sal\u00f3 de la farm\u00e0cia programa tres pon\u00e8ncies i una taula rodona a la Sala Espai Debat COVID per analitzar de la m\u00e0 d’experts i investigadors capdavanters els or\u00edgens, l’evoluci\u00f3 i les estrat\u00e8gies avan\u00e7ades per\u00a0 sortir de la pand\u00e8mia. \u00a0 Madrid, 15 de febrer. Infarma Madrid 2022 […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77022","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=77022"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77022\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/77023"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=77022"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=77022"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=77022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}